Aronex Pharma (ARNX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aronex Pharma (ARNX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tara Cobble who wrote (14)	4/10/1997 1:58:00 AM
From: Lance P. Dykhoff	of 320

Tara If the phase two trials come out promising, I don't see Genzyme giving up the rights, which means Aronex receives 3.0 million (2.0 million already received) plus royalties on sales. I think you are right about the corrections, I can't think of anything else for the drop in price, I only hold Aronex in this sector. If you go to Quotes and get a quote for Aronex (check off detailed) look at the research option. Two brokerages are carrying Aronex as a strong buy. Which two would be interesting to find out. It will also show an industry ranking (Aronex is 7 out of 113) I've got to hold since I got in right before the 1 for 2 split, my breakeven is $14.00, luckily I have a small position. At this price it's tempting to accumulate and bring my basis down a bit. I watching for now. Regards Lance

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next